Understanding Eye complications of Stevens–Johnson syndrome and TEN
SJS and TEN lie on a spectrum of severe immune-mediated skin and mucosal injury. Medicines are an important trigger, but diagnosis and identification of a culprit require hospital assessment rather than a self-diagnosis from eye symptoms. [1] [3]
Eye involvement can range from mild inflammation to loss of surface epithelium and major scarring. The degree of skin injury is not a reliable substitute for an eye examination, and acute treatment does not guarantee freedom from chronic ocular disease. [2] [4]
One condition. Different experiences.
Explore different selected symptom features, then read how they may vary. These examples are not stages or a clinical test.
Original VisualSim schematic illustrations, informed by the cited clinical descriptions. These are not study figures, patient recordings or validated severity levels.
Acute soreness and surface injury
Redness, watering, light sensitivity and blurred vision may occur during the systemic illness. Eye findings can evolve, including damage to the lid margins, cornea and conjunctiva. [2]
Persistent dryness and rubbing
After recovery, tear-system damage, inward lashes or a roughened inner lid margin can repeatedly injure the cornea. Burning and light intolerance can interfere with work, travel and reading. [4]
Variable long-term clarity
Surface irregularity, opacity and other complications can reduce vision; others maintain good measured acuity but still have uncomfortable or demanding daily visual tasks. Function and acuity deserve separate discussion. [5] [7]
Different phases, different eye-care goals
Original educational timeline; phases overlap and do not impose a fixed treatment schedule. [2] [3]
Original VisualSim teaching diagram · © VisualSim. Clinical basis in linked sources; not a published study figure. Image provenance.- Acute injury
Assess and protect the ocular surface during the systemic emergency.
- Healing and scarring
Monitor lid margins, tears and the cornea as the acute illness settles.
- Long-term function
Treat remaining mechanical and surface problems and support everyday vision.
What is happening—and what remains uncertain
Acute immune injury affects the surface epithelium and can produce membranes, erosions and inflammation. The ophthalmic team assesses the entire surface, including the inner lids and conjunctival folds, rather than only the center of the cornea. [2] [3]
Later damage can involve deficient tears, scarring, lid malposition, abnormal keratinization and loss of limbal stem-cell function. These mechanisms can interact, so treating one symptom such as dryness may leave a mechanical source of repeated injury. [4]
What can look similar?
Dry-eye disease can be a consequence
Lubrication is important when indicated, but a scarred or keratinized lid margin and misdirected lashes need separate assessment. Chronic ocular SJS/TEN is not interchangeable with uncomplicated dry eye. [4]
MMP is a different scarring disease
Ocular mucous membrane pemphigoid can also scar the conjunctiva, but its immune process, diagnostic pathway and usual treatment context differ from an acute SJS/TEN episode. [2] [4]
A new corneal wound has several possible causes
A persistent defect may involve lid rubbing, tear failure, inflammation, reduced sensation or infection. The cause of a late visual decline should not be assumed from the past SJS/TEN diagnosis alone. [2]
Similar-looking symptoms can have different causes. A matching picture cannot establish a diagnosis.
What an assessment may involve
- Early and repeated ophthalmic reviewAcute SJS/TEN requires prompt eye assessment and reassessment as findings change, even when ocular symptoms or skin involvement initially appear limited. Specialist examination establishes severity and the need for protection. [2] [3]
- Long-term surface and lid examinationFollow-up checks tear function, lid position and margins, lashes, conjunctival adhesions, corneal clarity and epithelial integrity. Vision and eye pressure are assessed as appropriate. [4]
- Measure real-world burdenDescribe reading tolerance, light sensitivity, discomfort and treatment-handling difficulties in addition to chart acuity. These concerns can help plan optical rehabilitation and practical support. [5] [7]
What may help—and what is still being studied
Acute care is coordinated in hospital
The systemic team evaluates suspected medicines and supportive care while the eye team manages inflammation, surface protection and complications. Do not attempt membrane removal or copy professional drop protocols at home. [1] [3]
Amniotic membrane has a defined role
For selected acute surface injury, early amniotic membrane treatment can help preserve the ocular surface. Extent of coverage, timing, clinical stability and local expertise matter; observational results do not prove one technique prevents every late complication. [2] [6]
Chronic care targets the remaining mechanisms
Prescribed surface treatment, lash or lid procedures and specialist scleral lenses may help selected people. Complex reconstruction requires a stable surface and careful risk discussion; a lens or graft is not a universal cure for the underlying injury. [4] [7]
What this can mean for daily life
Keep a documented medicine-reaction plan
Ask the hospital team which drug or drugs are implicated, which alternatives or related drugs require caution, and how this is recorded for future prescribers. Do not independently test a suspected culprit again. [1] [3]
Make eye care sustainable
Request clear instructions for prescribed drops or lens handling, practical training and help with costs or transport. Specialist lenses require fitting and follow-up rather than an ordinary cosmetic-lens purchase. [4] [7]
Adapt light and reading demands
Adjustable lighting, larger text, audio options and planned pauses can support participation when glare or discomfort limits visual endurance. Discuss safe driving with the treating team and applicable licensing rules. [4] [7]
Include emotional recovery and family support
A serious acute illness and persistent symptoms can affect confidence, relationships and work. Survivor groups and rehabilitation can help with coping and access while medical follow-up continues. [3]
Bring a clearer description to your appointment
Choose the questions you want to discuss. These choices stay in this page’s memory.
Research, with the context left in
Selected studies and guidance, with their populations and limitations. These are curated educational summaries, not a complete systematic review or a formal evidence rating.
Long-term amniotic membrane outcomes in acute SJS/TEN
At final follow-up 48 of 55 eyes had acuity of 20/40 or better, but dry eye and meibomian-gland disease remained common. [5]
Limits and applicability: Selected treated survivors, no randomized untreated comparator and two eyes per person limit causal inference. Good chart acuity did not mean absence of chronic morbidity.
Amniotic membrane outcomes: systematic review
Reported outcomes favor early acute membrane use and suggest coverage matters, while chronic use has a more limited supporting role. [6]
Limits and applicability: Evidence was largely observational and methodologically heterogeneous; direct technique comparisons were limited. This synthesis may include the 2020 cohort rather than providing a separate treated population.
PROSE treatment after SJS/TEN
Median acuity improved from 20/60 to 20/25 after customization, and mean NEI VFQ-25 score rose from 48 to 72. [7]
Limits and applicability: No randomized comparator; referral, successful treatment and follow-up selection limit generalization. This does not validate a 100% benefit claim or guarantee that every scarred eye can be fitted.
Questions researchers still need to answer
- Which acute treatment timing and coverage best preserve long-term comfort and function across severity groups?
- How can chronic-care studies better compare lid procedures, surface therapies and scleral-lens rehabilitation using patient-important outcomes?
Trusted places to go next
Selected clinical references, research, practical support and ways to connect. Official pages checked 24 October 2026; each entry explains its scope and region.
Stevens–Johnson Syndrome Canada
Condition-specific education, counseling information and support meetings. The official page lists upcoming 2026 virtual events; meeting access and service eligibility should be checked directly.
Connections listed by the organization.
SJS Awareness UK
Survivor and family support, educational material and research connections. Public support information is accessible; some member services require registration. Peer support is not emergency care or individual prescribing.
Connections listed by the organization.
BostonSight PROSE: clinic and access information
Information about specialist lens assessment, medical insurance and possible financial assistance for qualifying people. Access, fees and eligibility vary; provider surveys do not establish universal effectiveness.
RNIB community connection and wellbeing
Broader peer connection for people affected by persistent sight difficulties and their families; not a condition-specific group or medical advice. Check each service’s geographic eligibility.
Connections listed by the organization.
Questions you may still have
Should mild skin disease mean the eyes are safe?
No. Eye severity needs its own assessment and can change during the acute illness. [2] [4]
Can problems continue after hospital discharge?
Yes. Dryness, lid and lash abnormalities, scarring and corneal complications can persist or develop later. Follow-up remains important. [4] [5]
Does amniotic membrane prevent every complication?
No. It may reduce severe long-term injury in appropriate acute cases, but chronic surface and lid problems can still occur. [5] [6]
Is PROSE a cure?
No. Specialist scleral-lens treatment can improve selected symptoms and visual function, but suitability and outcomes vary and ongoing care is still needed. [7]
Sources, image credits and review status
Compiled by VisualSim from clinical references and published research. Sources checked 24 October 2026. Independent clinical review has not been recorded; no named clinical reviewer or clinical validation is claimed. Research evidence and its limitations are linked below.
- NHS: Stevens–Johnson syndrome (n.d.; institution).
Opened the relevant source text; educational material, not independent clinical review.
Checked 2026-10-24 · Public page checked - Metcalfe and colleagues: Acute and chronic management of ocular SJS/TEN in the USA (2021; review).
Opened the relevant source text; educational material, not independent clinical review.
Checked 2026-10-24 · Full text checked - Paulmann and colleagues: S3 epidermal-necrolysis guideline—Part2 supportive care (2024; guideline).
Opened the relevant source text; educational material, not independent clinical review.
Checked 2026-10-24 · Full text checked - Ocular involvement in SJS/TEN: current management and changing trends (2025; review).
Original indexed clinical sections checked; direct PMC challenge. Stage protocols interpreted as specialist care, not home instructions.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - Shanbhag and colleagues: Long-term outcomes of amniotic membrane treatment (2020; observational).
Author-institution abstract opened; 55 eyes from 29 patients; median 2.5-year follow-up.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - Pickens and colleagues: Ocular outcomes of amniotic membrane transplantation—systematic review (2026; systematic review).
Opened the relevant source text; educational material, not independent clinical review.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - Papakostas and colleagues: PROSE for ocular surface disease after SJS/TEN (2015; observational).
Original indexed abstract checked; 2014 online/2015 issue; 86 patients and 167 eyes; selected nonrandom cohort.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed
The simulator helps people communicate an experience. It cannot diagnose a condition, measure a visual field, or establish that someone is safe to drive.